Memorial Sloan Kettering: Rockefeller Outpatient Pavilion

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

AIDS-Related Kaposi Sarcoma, BRAF V600E-mutant Metastatic Colorectal Cancer, HIV Infection, Recurrent Kaposi Sarcoma

Studies at this site

• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma — Completed